AGP Picks
View all

Healthy Living Europe
Provided by AGP

Healthy Living Europe: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthy Living Europe.

May 2026

Mo Tu We Th Fr Sa Su
1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31

June 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

July 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

Press releases published on April 16, 2026

Dr. Falk Pharma and Renexxion Announce Late-Breaker Oral Presentation of Global Phase 2b Gastroparesis Results at Digestive Disease Week (DDW) 2026
Apr. 16, 2026

Dr. Falk Pharma and Renexxion Announce Late-Breaker Oral Presentation of Global Phase 2b Gastroparesis Results at Digestive Disease Week (DDW) 2026

Indeterminate GlobeNewswire
INmune Bio Inc. Announces New Preclinical Data at AACR 2026 Demonstrating INB03 (XPro1595) Overcomes Resistance and Reduces Metastases in HER2-Positive Breast Cancer Models
Apr. 16, 2026

INmune Bio Inc. Announces New Preclinical Data at AACR 2026 Demonstrating INB03 (XPro1595) Overcomes Resistance and Reduces Metastases in HER2-Positive Breast Cancer Models

Indeterminate GlobeNewswire
Pacira to Report First Quarter 2026 Financial Results on Thursday April 30, 2026
Apr. 16, 2026

Pacira to Report First Quarter 2026 Financial Results on Thursday April 30, 2026

Indeterminate GlobeNewswire
Wellcome Leap Announces $2 Million Prize in $50 Million Quantum for Bio Challenge Program
Apr. 16, 2026

Wellcome Leap Announces $2 Million Prize in $50 Million Quantum for Bio Challenge Program

Indeterminate GlobeNewswire
Aktis Oncology Appoints Industry Research and Development Veteran Glenn Gormley, MD, PhD to its Board of Directors
Apr. 16, 2026

Aktis Oncology Appoints Industry Research and Development Veteran Glenn Gormley, MD, PhD to its Board of Directors

Indeterminate GlobeNewswire
Elicio Therapeutics Reports Inducement Grants
Apr. 16, 2026

Elicio Therapeutics Reports Inducement Grants

Indeterminate GlobeNewswire
MIMEDX Announces Restructuring and Cost Reduction Initiative
Apr. 16, 2026

MIMEDX Announces Restructuring and Cost Reduction Initiative

Indeterminate GlobeNewswire
VTAK Definitive Agreement to Acquire 100% of Fly Flyte Inc. Obtains Shareholder Approval
Apr. 16, 2026

VTAK Definitive Agreement to Acquire 100% of Fly Flyte Inc. Obtains Shareholder Approval

Indeterminate GlobeNewswire
Totus Medicines to Present First-in-Class Covalent IRF5 Inhibitor Data at AAI IMMUNOLOGY2026
Apr. 16, 2026

Totus Medicines to Present First-in-Class Covalent IRF5 Inhibitor Data at AAI IMMUNOLOGY2026

Indeterminate GlobeNewswire
Prime Medicine Appoints Svetlana Makhni as Chief Financial Officer
Apr. 16, 2026

Prime Medicine Appoints Svetlana Makhni as Chief Financial Officer

Indeterminate GlobeNewswire
Medera Receives FDA Fast Track Designation for Gene Therapy Targeting Duchenne Muscular Dystrophy-Associated Cardiomyopathy
Apr. 16, 2026

Medera Receives FDA Fast Track Designation for Gene Therapy Targeting Duchenne Muscular Dystrophy-Associated Cardiomyopathy

Indeterminate GlobeNewswire
EDAP to Announce First Quarter 2026 Financial Results on May 7, 2026
Apr. 16, 2026

EDAP to Announce First Quarter 2026 Financial Results on May 7, 2026

Indeterminate GlobeNewswire
Xilio Therapeutics Appoints Cheryl R. Blanchard, Ph.D. to its Board of Directors
Apr. 16, 2026

Xilio Therapeutics Appoints Cheryl R. Blanchard, Ph.D. to its Board of Directors

Indeterminate GlobeNewswire
Paratek Pharmaceuticals to Present New Data on NUZYRA® (omadacycline) at ESCMID Global 2026
Apr. 16, 2026

Paratek Pharmaceuticals to Present New Data on NUZYRA® (omadacycline) at ESCMID Global 2026

Indeterminate GlobeNewswire
Korro Announces Oral and Poster Presentations at Upcoming Scientific Conferences
Apr. 16, 2026

Korro Announces Oral and Poster Presentations at Upcoming Scientific Conferences

Indeterminate GlobeNewswire
Helus Pharma Strengthens Medical Leadership by Appointing Dr. Ken Kramer as Senior Vice President, Medical Affairs
Apr. 16, 2026

Helus Pharma Strengthens Medical Leadership by Appointing Dr. Ken Kramer as Senior Vice President, Medical Affairs

Indeterminate GlobeNewswire
Kane Biotech Presents revyve® Clinical Data at Symposium on Advanced Wound Care (SAWC) Spring Conference
Apr. 16, 2026

Kane Biotech Presents revyve® Clinical Data at Symposium on Advanced Wound Care (SAWC) Spring Conference

Indeterminate GlobeNewswire
Alterity Therapeutics Announces Late-Breaker Oral Presentation at the American Academy of Neurology Annual Meeting
Apr. 16, 2026

Alterity Therapeutics Announces Late-Breaker Oral Presentation at the American Academy of Neurology Annual Meeting

Indeterminate GlobeNewswire
MeiraGTx Announces the Acquisition of Botaretigene Sparoparvovec (bota-vec) for the Treatment of X-linked Retinitis Pigmentosa (XLRP)
Apr. 16, 2026

MeiraGTx Announces the Acquisition of Botaretigene Sparoparvovec (bota-vec) for the Treatment of X-linked Retinitis Pigmentosa (XLRP)

Indeterminate GlobeNewswire
Beamion LUNG-1 study results for zongertinib in treatment-naïve patients with HER2-mutant advanced NSCLC published in The New England Journal of Medicine
Apr. 16, 2026

Beamion LUNG-1 study results for zongertinib in treatment-naïve patients with HER2-mutant advanced NSCLC published in The New England Journal of Medicine

Indeterminate GlobeNewswire
Show More

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Healthy Living Europe

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.